||
Afamitresgene autoleucel (原名ADP-A2M4,缩写afami-cel)是一种靶向MAGE-A4癌症抗原的过继T细胞受体(TCR)疗法,在由德克萨斯大学MD安德森癌症中心的研究人员领导的I期临床试验中,对多种实体肿瘤类型的患者取得了显著临床疗效。
https://www.ebiotrade.com/newsf/2023-1/20230110102112974.htm
http://www.pubmedplus.cn/P/SearchQuickResult?wd=1a595ab4-7e2f-402b-8273-3aff32262130
01. | Humans | 4 篇 | 0.195% |
02. | Animals | 2 篇 | 0.097% |
03. | Immunotherapy, Adoptive | 2 篇 | 0.097% |
04. | Neoplasms | 2 篇 | 0.097% |
05. | Receptors, Antigen, T-Cell, gamma-delta | 2 篇 | 0.097% |
06. | Aged | 1 篇 | 0.049% |
07. | Aminoquinolines | 1 篇 | 0.049% |
08. | Antigen-Presenting Cells | 1 篇 | 0.049% |
09. | Antigens, CD19 | 1 篇 | 0.049% |
10. | Antineoplastic Combined Chemotherapy Protocols | 1 篇 | 0.049% |
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-7-28 02:31
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社